RETN
Resistin
Also known as: ADSF, FIZZ3, RETN_HUMAN, RETN1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HD89
- Gene
- RETN
- Ensembl
- ENSG00000104918
- Chromosome
- 19
- Canonical length
- 108 aa
- Protein class
- Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene belongs to the family defined by the mouse resistin-like genes. The characteristic feature of this family is the C-terminal stretch of 10 cys residues with identical spacing. The mouse homolog of this protein is secreted by adipocytes, and may be the hormone potentially linking obesity to type II diabetes. The encoded protein also has an antimicrobial role in skin, displaying antibacterial activity against both Gram positive and Gram negative bacteria. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2020]
Canonical amino-acid sequenceUniProt
108 residues, UniProt reviewed canonical sequence.
>Q9HD89|RETN
1 MKALCLLLLP VLGLLVSSKT LCSMEEAINE RIQEVAGSLI FRAISSIGLE CQSVTSRGDL
61 ATCPRGFAVT GCTCGSACGS WDVRAETTCH CQCAGMDWTG ARCCRVQPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RETN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 233 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 233 nTPM
- spleen: 57 nTPM
- lung: 35 nTPM
- duodenum: 5.7 nTPM
- appendix: 4.9 nTPM
- smooth muscle: 4 nTPM
Single-cell type
- neutrophil progenitors: 3,157 nCPM
- monocyte progenitors: 596 nCPM
- neutrophils: 267 nCPM
- hofbauer cells: 218 nCPM
- monocytes: 163 nCPM
- macrophages: 34 nCPM
Immune cell
- classical monocyte: 171 nTPM
- myeloid DC: 119 nTPM
- intermediate monocyte: 92 nTPM
- total PBMC: 64 nTPM
- non-classical monocyte: 48 nTPM
- neutrophil: 14 nTPM
Brain region
- cerebral cortex: 2.8 nTPM
- basal ganglia: 1 nTPM
- hypothalamus: 1 nTPM
- amygdala: 0.9 nTPM
- hippocampal formation: 0.9 nTPM
- pons: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.79
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.12
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fat cell differentiation
- negative regulation of feeding behavior
- positive regulation of synaptic transmission
- response to insulin
- response to mechanical stimulus
- positive regulation of progesterone secretion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RETN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RETN as an antibody target. Whether an autoantibody or antibody against RETN could matter depends on whether native RETN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RETN is annotated as secreted, so native RETN circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label RETN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...